Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumateperone Adjunctive to Lithium or Valproate in Bipolar Depression
NCT02600507Phase 3Completed
- Sponsor
- Intra-Cellular Therapies
- Start
- Mar 2016
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of lumateperone in bipolar disorder (BD), sponsored by Intra-Cellular Therapies. Started Mar 2016; status: completed.
02
Drugs
lumateperone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02600507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02600507.